This observation, coupled with the finding that VEGFR2 treatment decreased eNOS and iNOS mRNA expression, suggests that VEGF may act to reduce BP via induction of NO and that VEGF inhibitor-mediated hypertension may be at least in part due to inhibition of NO (37). The gene discussed is VEGFA; the disease is hypertensive disorder.